Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1601.HK Stock Summary
In the News
1601.HK Financial details
Company Rating
Strong Buy
Market Cap
866.66M
Income
133.44M
Revenue
291.24M
Book val./share
-
Cash/share
-
Dividend
0.05
Dividend %
9.18%
Employees
136
Optionable
No
Shortable
Yes
Earnings
17 Mar 2023
P/E
3.87
Forward P/E
1.86
PEG
-2.32
P/S
1.85
P/B
0.37
P/C
-
P/FCF
-1.11
Quick Ratio
-
Current Ratio
-
Debt / Equity
3.51
LT Debt / Equity
2.79
-
-
EPS (TTM)
0.1
EPS next Y
0.35
EPS next Q
-
EPS this Y
25%
EPS next Y
245.02%
EPS next 5Y
245.02%
EPS last 5Y
15.47%
Revenue last 5Y
14.5%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-1.54%
SMA50
-3.03%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
2%
ROE
10%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
48%
Payout
30%
Shs Outstand
1.33B
Shs Float
0
-
-
-
-
Target Price
-
52W Range
0.59-0.8
52W High
-
52W Low
-
RSI
51.53
Rel Volume
4.23
Avg Volume
119.54K
Volume
506K
Perf Week
1.56%
Perf Month
1.56%
Perf Quarter
-7.14%
Perf Half Y
-8.45%
-
-
-
-
Beta
1.00524
-
-
Volatility
0%, 0.01%
Prev Close
1.56%
Price
0.65
Change
0%
1601.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.16 | 0.19 | 0.23 | 0.28 | 0.31 | |
Net income per share | 0.07 | 0.09 | 0.1 | 0.12 | 0.15 | |
Operating cash flow per share | 0.09 | -0.41 | -0.42 | 0.03 | -0.51 | |
Free cash flow per share | 0.08 | -0.41 | -0.42 | 0.02 | -0.51 | |
Cash per share | 0.24 | 0.23 | 0.19 | 0.31 | 0.49 | |
Book value per share | 0.9 | 0.97 | 1.04 | 1.46 | 1.54 | |
Tangible book value per share | 0.9 | 0.96 | 1.04 | 1.45 | 1.53 | |
Share holders equity per share | 0.9 | 0.97 | 1.04 | 1.46 | 1.54 | |
Interest debt per share | 2.12 | 2.72 | 3.37 | 3.9 | 4.64 | |
Market cap | 1.68B | 1.76B | 1.81B | 1.33B | 924.97M | |
Enterprise value | 4.02B | 4.92B | 5.83B | 5.81B | 6.21B | |
P/E ratio | 17.24 | 14.83 | 13.07 | 8.21 | 4.72 | |
Price to sales ratio | 8.05 | 6.91 | 5.96 | 3.66 | 2.25 | |
POCF ratio | 14.79 | -3.26 | -3.23 | 35.63 | -1.37 | |
PFCF ratio | 14.85 | -3.25 | -3.2 | 48.98 | -1.36 | |
P/B Ratio | 1.4 | 1.37 | 1.3 | 0.69 | 0.45 | |
PTB ratio | 1.4 | 1.37 | 1.3 | 0.69 | 0.45 | |
EV to sales | 19.3 | 19.24 | 19.21 | 16.02 | 15.14 | |
Enterprise value over EBITDA | 14.07 | 15 | 13.96 | 12.56 | 11.79 | |
EV to operating cash flow | 35.46 | -9.07 | -10.41 | 156.09 | -9.19 | |
EV to free cash flow | 35.58 | -9.05 | -10.31 | 214.58 | -9.11 | |
Earnings yield | 0.06 | 0.07 | 0.08 | 0.12 | 0.21 | |
Free cash flow yield | 0.07 | -0.31 | -0.31 | 0.02 | -0.74 | |
Debt to equity | 3.16 | 3.64 | 4.02 | 3.26 | 3.59 | |
Debt to assets | 0.76 | 0.78 | 0.8 | 0.77 | 0.78 | |
Net debt to EBITDA | 8.2 | 9.61 | 9.63 | 9.7 | 10.03 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.87 | -3.41 | -3.03 | 0.17 | -2.59 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.04 | 0.06 | |
Payout ratio | 0.31 | 0.29 | 0.25 | 0.31 | 0.3 | |
Sales general and administrative to revenue | 0 | 0.01 | 0.02 | 0.03 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0.01 | -0.27 | 0.01 | |
Capex to revenue | 0 | 0 | -0.02 | -0.03 | -0.01 | |
Capex to depreciation | -0.54 | -1.61 | -0.46 | -0.72 | -0.29 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.22 | 1.39 | 1.56 | 2.01 | 2.26 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham Net | -2.6 | -3.26 | -4 | -4.43 | -5.04 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 1.2B | 1.28B | 1.39B | 1.91B | 2.04B | |
Net current asset value | -3.8B | -4.68B | -5.6B | -6.25B | -7.37B | |
Invested capital | 2.22 | 2.68 | 3.07 | 2.56 | 2.89 | |
Average receivables | 1.31M | 16.01M | 19.52M | 7.76M | 6.15M | |
Average payables | 71.1M | 100.2M | 106.97M | 84.54M | 91.59M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 3.01 | 43.29 | 10.52 | 6.82 | 4.91 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 121.19 | 8.43 | 34.69 | 53.51 | 74.32 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.08 | 0.09 | 0.1 | 0.08 | 0.1 | |
Capex per share | 0 | 0 | 0 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
Metric | History | 2020-06-30 | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 3.67B | 4.48B | 4.48B | 5.29B | 5.4B | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 3.04 | 3.26 | 3.21 | 3.59 | 3.51 | |
Debt to assets | 0.75 | 0.77 | 0.76 | 0.78 | 0.78 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 1.83B | 1.91B | 1.94B | 2.04B | 2.09B | |
Net current asset value | -5.57B | -6.25B | -6.28B | -7.37B | -7.39B | |
Invested capital | 2.29 | 2.56 | 2.51 | 2.89 | 2.79 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
1601.HK Frequently Asked Questions
What is Zhongguancun Science-Tech Leasing Co., Ltd. stock symbol ?
Zhongguancun Science-Tech Leasing Co., Ltd. is a CN stock and trading under the symbol 1601.HK
What is Zhongguancun Science-Tech Leasing Co., Ltd. stock quote today ?
Zhongguancun Science-Tech Leasing Co., Ltd. stock price is $0.65 today.
Is Zhongguancun Science-Tech Leasing Co., Ltd. stock public?
Yes, Zhongguancun Science-Tech Leasing Co., Ltd. is a publicly traded company.